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ABSTRACT 
Purpose: The aim of this study was to investigate the effect of smokeless tobacco (ST) upon 
recovery time. Specifically, we wanted to investigate the effect of ST in the time to recover 
peak power (PP), peak force (PF) and maximal voluntary isometric contraction (MVIC) after 
a fatiguing leg-extension exercise. It was hypothesized that use of ST would lead to delayed 
time of recovery in muscular force and power following a fatiguing leg-extension exercise. It 
was also hypothesized that PF and PP would be lower, and time-to PF (TtPF) and PP (TtPP) 
would be higher, with use of ST than without. Method: Six male ST users playing football at 
the third level in Norway volunteered to participate in the study. To analyze the effects of 
smokeless tobacco on recovery time, the six male ST users were initially tested seated in a 
plate loaded leg extension apparatus:  i) 1RM; ii) maximal voluntary contraction at 50% of 
1RM (MVC50); iii) peak power (PP50) and peak force (PF50) in the MVC50; iv) TtPP (TtTP50) 
TtPF (TtPF50) in the MVC50 and; v) maximal voluntary isometric contraction (MVIC). After 
these baseline tests the subjects were randomly tested according to an AB design. In either 
conditions, A and B, the test started with a fatigue stimulation bout of the muscles involved in 
the leg extension exercise, until exhaustion. After ending the fatigue stimulation protocol, the 
subjects remained seated in the leg extension apparatus and, every other minute; they 
performed one repetition with a load corresponding to MVC50. Force and power variables 
were registered during these repetitions, and when the subjects reached their baseline values, 
they were considered to be recovered from the fatigue stimulation. These tests were 
conducted within the first 30 minutes of the recovery period. Results: No significant 
differences were revealed upon any of the scores obtained in baseline and during the recovery 
tests, with or without ST in PP50, mean PP50 and TtPP50. Significant effect of time was found  
in the PP50 during the recovery test, but no effects of ST or interaction between time and ST 
during the PP50 recovery test were found. No significant differences were revealed obtained 
from the baseline scores, with or without ST in PF50 during the recovery tests, but the subjects 
mean PF50 proved to be significant higher with ST than without during the recovery test, and 
the TtPF50 was significantly higher than the scores obtained in baseline. The time to recover 
PF50 during the recovery test, proved significant increased with use of ST, compared to 
without use of ST. MVIC at baseline proved to be significantly higher than the MVIC scores 
during the recovery test without ST.   
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INTRODUCTION 
The aim of this study was to investigate the effect of smokeless tobacco (ST) upon recovery 
time. Specifically, we wanted to investigate the effect of ST in the time to recover peak power 
(PP), peak force (PF) and maximal voluntary isometric contraction (MVIC) after a fatiguing 
leg-extension exercise. 
In Scandinavia the use of ST is extensive, and has increased during the last decades. This is 
particularly reflected among youths (Nordgren & Ramstrøm, 1990; Pershagen 1996). A 
Norwegian survey shows that approximately 10% of Norwegian youths daily uses ST, and 
almost 20% have tried it once or more (SIRUS, 2007). Several studies report that ST seems to 
be more extensive among athletes than none-athletes (Davis, 1997; Melnick, 1997; Escher, 
1998). Today there is a number of studies surrounding ST. Mostly they concerns health and 
the risk of disease (Pershagen, 1996; Benowitz, 1998; Asplund, 2003), and the acute physical 
performance (Schroeder & Chen, 1985; Ksir et al., 1986; Edwards et al., 1987; Glover et al., 
1989; Guggenheimer, 1991; Landers et al., 1992; Van Duser & Raven, 1992; Escher, 1998;  
Edquist, 2004; Karlsen, 2004).  Rather few studies seem to deal with fatigue recovery. 
Smokeless tobacco originates from the tobacco plant Nicotiana. The tobacco is dried and 
treated so the finished product for sale appears to be a damp dark mass (Strømme, 2001). 
Processed tobacco contains as much as 2000 chemical compounds, and a numerous additives 
such as salt, ammonia, spices and condiments (Pershagen, 1996). Alkaline buffer agents are 
added to the ST, for example sodium carbonate, potassium carbonate and potassium- 
bicarbonate. This results in that ST is a fairly strong alkaline with a pH value between 8.0 and 
9.5 (Pershagen, 1996). Nicotine is a liquid alkaloid with the chemical formula C10H14N2. Such 
drugs have proved a significant effect on the organism, and they are known from the 
pharmaceutical industry, for example in morphine (Edquist, 2004). Smokeless tobacco can 
have both a stimulating and a calming effect on the nervous system, and it is suggested that 
the alkaloids exerts its effect by binding to receptors in the brain (Edquist, 2004).   The 
receptors lead to an increased release of signaling substances which triggers other reactions in 
the organism, including the endocrine process resulting in an increase of dopamine. Some 
authors claim the nicotine to be at greatest extent to the nicotinic receptors in sympathetic 
ganglia and the adrenal medulla, which leads to increased secretion of epinephrine and 
norepinephrine (Cryer et al., 1976; Guggenheimer, 1991; Lumbardo, 1998; Edquist, 2004).  
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In the present study, muscle fatigue is one of the main 
variables. Muscle fatigue is defined by Vøllestad (1997, 
p.222); ‘as a reduction in the maximal strength 
generating capacity caused by muscle contraction’.  It is 
common to divide fatigue into central and peripheral 
fatigue. Central fatigue is often defined as; ‘a decline 
caused by a reduction in the firing frequency of the 
motoneurons’ (Åstrand et al. 2005, p.457). Peripheral 
fatigue is by Åstrand et al. (2003, p.457) defined as; ‘a 
force or power deficit that occurs despite optimal 
activation of the muscle fibers by their motoneurons’.  
During sustained muscle actions, central and peripheral 
fatigue has proved to develop during maximal, as well as 
submaximal voluntary efforts (Bigeland-Ritchie et al., 
1983; Löscher et al., 1996). At intermittent muscle 
actions during maximal effort, both central en peripheral 
fatigue has shown to develop (Taylor et al., 2000), 
whereas at submaximal effort or when there is sufficient rest between each action, fatigue has 
shown mainly to be due peripheral mechanisms (Bigeland-Ritchie et al., 1986).The 
impairment of performance resulting from muscle fatigue differs according to physical 
fitness, type of contraction involved, the duration and intensity of the exercise and muscle 
groups tested (Bigeland et al., 1986).  
A voluntary force generation results from a sequence of events. Åstrand et al., (2003, p.455) 
points to that fatigue might be caused by deficient function in the chain of command during a 
voluntary activation of skeletal muscles, at any of these steps (Fig. 1). The first thing pointed 
out in the chain, concerns all central factors which influence the activation of the 
motoneurons, motivational factors or the sensory information (Vøllestad, 1997). 
It has been suggested that central fatigue might be due to suboptimal facilitation from motor 
cortex (Taylor et al., 2000), decreased facilitation from the muscles spindles, increased 
inhibition from group III and IV afferents (Åstrand et al., 2003, p.462-463) and a decreased 
sensitization of the motoneurons (Kernell, 1969).  
SSSuprespinal levels 
↓ 
Excitation of motoneurons 
↓ 
Excitation of muscle units 
↓ 
Release of Ca++ from SR 
And binding of Ca++ to Tnc 
↓ 
Crossbridge cycling 
↓ 
Force and power output 
Figure 1: The chain of command during 
voluntary activation of a skeletal muscle 
(Åstrand et al. 2003, p.455). 
5 
 
In the next step these central factors leads to generation of action potentials (AP) at the 
sarcolemma. During exercise the balance of Na+/K+ ions over the sarcolemma and t-tubule 
membrane changes, which might impair the propagation of the AP (Vøllestad, 1997). A 
consequence of this is that the amount of Ca2+ release from sarcoplasmatic reticulum (SR) into 
the cytosol decreases, which in next step might influence the binding of Ca2+ to the troponin 
C. A result of this is reduced bindings between actin and myosin, which leads to decreased 
force per cross bridge, and in turn lower force and power.  
 
The cross-bridge cycling during maintenance of force is highly dependent upon sufficient 
supply of ATP through aerobic/anaerobic pathways. Metabolic factors such as lactate, 
hydrogen ion (H+) and inorganic phosphate (Pi) in association to peripheral fatigue has been 
investigated for ages. The accumulation of lactic acid in the muscle has historically been 
suggested to be the major cause of muscle fatigue. However, the raised levels of H+-ions 
which results in reduced pH, has proved to be of a much greater impact (Westerblad & Allen, 
2002).     
 
Fatigue recovery is considered to be how the organism regains its metabolic balance and force 
production back to resting levels (Allen et al. 2008).  In the present study recovery is 
considered to start immediately after the fatigue stimulation period. This means that the 
fatigue-induced impairment in muscle function does not necessarily have to improve during 
the initial part of the recovery period. In fact the opposite is observed. For instance 
Westerblad & Allen (1986) demonstrated that fast-twitch frog muscle fibers showed a marked 
force decrease after the end of fatiguing stimulation. This has been named the post contractile 
depression (PCD).  
There might be different time courses of recovery and restoration of force production after a 
fatigue induced stimulation. In addition recovery of force after fatigue induced by repeated 
short tetani is proved completed within 30 min tested at high frequencies (close to maximal), 
whereas the level of force at low frequencies stimulation may be markedly depressed for 
hours (Westerblad & Allen, 1986).  
Edwards et al. (1977) and Hill et al. (2001) points to that following severe or prolonged 
exercise, the force deficit might be due to changes in muscle function that may last for hours.  
The deficit does not seem to be due to reduced levels of ATP or CrP, or the increase of 
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metabolites, because these returns close to resting levels within 15 to 60 min (Edwards et al. 
1977; Tupling et al., 2000; Hill et al., 2001).  
Fatigue concerns changes in isometric force, maximal shortening velocity and the curvature of 
the force-velocity relationship. The above mentioned factors have different underlying 
mechanism, which all affects the power output (Allen et al., 2008). A transient increase of 
inorganic adenosine phosphate (ADPi) appears to play a certain role at the decrease in 
maximal shortening velocity induced by fatigue. Inorganic phosphates or H+ has however 
proved to have little impact on this parameter. In addition Pi seems to decrease the 
myofibrillar capacity to generate force and impairs SR Ca+2 handling, which is earlier 
mentioned as one of the major causes of fatigue (Westerbald & Allen, 2002).   
Several studies have shown that ST increases heart rate and systolic blood pressure, both at 
rest and during exercise (Schroeder & Chen, 1985; Ksir et al., 1986; Edwards et al., 1987; 
Glover et al.,1989; Landers et al., 1992; Karlsen, 2004). Heart rate (HR) might increase as 
much as 15 beats per min (Guggenheimer, 1991; Edquist, 2004). This results from 
vasoconstriction, and decreases the ability to deliver oxygen (O2) to the muscle fibers as well 
as their utilization of O2 (Guggenheimer, 1991; Edquist, 2004; Åstrand et al., 2005, p.449). 
The raised level of carbon monoxide during use of smokeless tobacco is also proved to reduce 
the O2 transport. This is due to the hydrogen cyanide which inhibits the enzyme systems 
necessary for the oxidative metabolism (Åstrand et al. 2002, p.449). Van Duser and Raven 
(1992) demonstrated in ST users a significant increase in lactic acid concentration and 
lowered stroke volume during exercise at 60% and 85% of VO2max and at rest.  A study by 
Williams & Wilkins (1998) concluded that ST use had no effect on reaction time, but ST use 
may have detrimentally influenced the maximum voluntary force and maximum rate of force 
generation (Escher et al., 1998). Lester et al. (1988) suggested that ST use causes a delay in 
the nervous transmission across the neuromuscular junction. A urine output is also shown 
decreased with antidiuretic hormone levels, which increases satiety and in next step helps to 
decrease weight (Lombardo, 1986). Åstrand et al. (2002, p.448-449) reports associations 
between tobacco use and delayed tissue healing, and Silverstein (1992) observed a slower 
healing in wounds resulting from trauma, disease or surgical procedures.  
 
These findings indicate that ST might increase the time of fatigue recovery, and it was 
hypothesized that use of ST would lead to delayed time of recovery in muscular force and 
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power following a fatiguing leg-extension exercise. It was also hypothesized that PF and PP 
would be lower, and time-to PF and PP would be higher, with use of ST than without. 
MATERIALS AND METHODS 
 
Experimental Approach to the Problem  
To analyze the effects of smokeless tobacco on recovery time, six male ST users playing 
football were initially tested seated in a plate loaded leg extension apparatus (Fig.3):  i) 1RM; 
ii) maximal voluntary contraction at 50% of 1RM (MVC50); iii) peak power (PP50) and peak 
force (PF50) in the MVC50; iv) TtPP (TtTP50) TtPF (TtPF50) in the MVC50; and v) maximal 
voluntary isometric contraction (MVIC).). After these baseline tests the subjects were 
randomly tested according to an AB design. In either conditions, A and B, the test started with 
a fatigue stimulation bout of the main muscles involved in the leg extension exercise, i.e. QF, 
until exhaustion. The exercise was accomplished seated in the same leg extension apparatus 
as used in the baseline examination. After ending the fatigue stimulation protocol, the subjects 
remained seated in the leg extension apparatus and, every other minute; they performed one 
repetition with a load corresponding to MVC50. Force and power variables were registered 
during these repetitions, and when the subjects reached their baseline values, they were 
considered to be recovered from the fatigue stimulation. These tests were conducted within 
the first 30 minutes of the recovery period. Under condition A the subjects used ST during the 
recovery period after the fatigue stimulation bouts, whereas in B they abstained from ST 
twelve hours before testing and during the recovery period.  
Subjects 
Six male ST users playing football at the third level in Norway volunteered to participate in 
the study, which was approved by the Ethics Committee, Trondheim, Norway. Approval was 
also obtained from the Norwegian Data Inspectorate.  
The subjects met the following criteria: i) 18-25 years old; ii) involved in regular football 1.5 
hour per day at least 4 times a week in the last year; iii) they were in good health; iv) they all 
had experience with strength training and, in particular, they were experienced in the leg 
extension exercise applied in this study. The subjects were given oral and written information 
(appendix 1) about the purpose of the study, procedures, and possible risks of participating. 
Thereafter the subjects gave their written informed consent to participate in the study. The 
characteristics of the subjects’ are shown in (Tab.1). 
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Table 1: Anthropometrics and strength characteristics of the subjects at baseline (N=6)  
Subject Height (cm) Weight (kg) BMI 
1
1RM dynamic (kg) 
2
MVIC (N) 
1 192.1 80.3 21.7 176.3 1343.0 
2 180.3 74.2 22.8 181.3 1503.0 
3 176.2 68.2 22.0 148.3 1527.5 
4 176.0 68.0 22.0 148.3 1363.0 
5 190.1 81.0 22.4 159.3 963.8 
6 176.2 75.1 24.2 176.3 1510.0 
Mean: 181.8 74.5 22.5 165.0 1368.4 
1
The subjects 1RM in the seated leg extension exercise. 
2
The subjects maximal voluntary isometric contraction 
in the seated leg extension exercise. 
 
Procedure 
Pilot study 
Before the investigation started, a pilot study with sports science students from The Nord-
Troendelag University College was conducted.  We first determined each sport science 
students’ 1RM baseline value in the seated leg extension exercise. 
Afterwards different loads for the fatigue stimulation protocol were examined, as well as 
which load to use in the MVC during the recovery period. It was found that a load 
corresponding to 60% of 1RM in the fatigue stimulation protocol in combination with MVC 
at 50% of 1RM in the recovery period, brought the subjects back to baseline levels within 12 
to 25 min. Heavier loads in the fatigue stimulation protocol, and lower loads in the MVC 
during the recovery period, revealed that the subjects recovered too fast (6-12 min).   
Main study 
The subjects accomplished two days of training with the leg extension exercise applied in this 
study, in order to get familiarized with the testing equipment and the experimental protocol. 
This training consisted of 3x15 repetitions at a light weight.  
After this familiarization procedure, the subjects returned to the laboratory after 3 to 5 days in 
order to perform baseline examinations. The baseline examinations started with a 10 min 
warm up in a cycle ergo meter at 60% of their reported maximal HR. 
Thereafter 1RM in the seated leg extension apparatus was determined as described by 
Kraemer (1995, p.121), in order to calculate the loads to use in the fatigue stimulation 
protocol (60% 1RM) as well as the MVC50 in the recovery period. 
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After a 10 min break, the subjects MVC50 were determined. The highest measured PP and PF 
of
 
the subjects’ two trials represented the PP50 and PF50 baseline levels in the leg extension 
exercise at a MVC50. 
The subjects’ MVIC in the seated leg -extension apparatus was the last baseline test 
determined. The subjects performed a maximal isometric effort, and kept the contraction for 
three seconds. The PF during the MVIC of the subjects’ two trials represented their MVIC at 
baseline. 
During the next six days, the subjects revisited the laboratory two times, and was randomly 
assigned to accomplish A; one day of testing using ST during the test, and B; one day of 
testing abstaining from ST at minimum twelve hours before testing and during the test. The 
half-life of nicotine is ~2 h (Gritz et al., 1981; Benowitz, 1988). Twelve hours, or six 
degradation half-lives, would theoretically bring the nicotine level to near zero (Williams & 
Wilkins, 1998).  During condition B the subjects consumed one portion (1 gram) ST from the 
time they arrived the laboratory, until the test was ended. 
 
The warm up procedure was the same as described for the baseline tests. Thereafter the 
fatigue stimulation protocol seated in the leg extension apparatus at 60% of the subjects 1RM 
was initiated. The subjects accomplished three bouts of fatigue stimulation until exhaustion, 
with one min resting between each bout. A Weird metronome signaled the start of the 
movement every third second during the fatigue stimulation.  
 
When the fatigue stimulation bouts were finished, the subjects accomplished tests of recovery 
after 1,3,5,7,9,11,13,15,17,20,23,26 and 30 minutes. When the subjects had regained their 
MVC50 and MVIC to baseline levels, the session was ended. The subjects stayed passive 
(seated in the knee extension apparatus) during the recovery period. 
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MuscleLab 
In order to measure the dynamic and 
isometric muscle strength, the 
MuscleLab system 4010/4020e (Ergo 
test Technology, Langesund, Norway) 
was used. MuscleLab is designed to use 
the most common type of force sensor, 
and during the present study the load 
cell (333A) was used in both isometric 
and dynamic contractions. One of the 
variables in the dynamic contractions 
was power (P), and for this purpose a 
linear encoder was used in combination 
with the force transducer. The linear encoder measure motion as a function of time together 
with the load cell, and the MuscleLab Software then calculates distance, velocity and power. 
The MuscleLab 4010/4020e got installed to the leg extension apparatus (Fig. 3). Using 
MuscleLab 4010/4020e claims some calibration. We fastened a known weight at the power 
cell, in this case 80kg, and the load was set to 80kg (Fig. 6). Calibrating the linear encoder 
means defining the position to zero at the starting point of the extension. MuscleLab 
4010/4020 and Microsoft Excel (Version 2007; Microsoft Corporation, USA) were used in all 
calculations. 
 
 
 
 
 
 
 
 Figure 4: 1. Starting 
position. 2.Lever arm 
placed at superior extensor 
retinaculum. 3. Full 
extension (0
o
) 
Figure 5: Locking device, 
used during the isometric 
measurements. 
Figure 6: Calibration of 
the power cell. 
Figure 3: MuscleLab setup at the knee extension apparatus. 1. 
Power cell attached to the wire. 2. Linear encoder attached to 
the load plates. 3. Backrest. 4. Leg adjustment. 
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Data handling and calculations   
All the measurements, both MVC50 and MVIC were calculated from the starting position 
(knee angle at 90o) seated in the leg extension apparatus. The ending point in the dynamical 
movement was defined at full extension (knee angle at 0o) (Fig. 4). The superior side of the 
subjects’ ankle was pressing against the pads, and the knee in line with the rotation cam of the 
machine.  
The results of the MVC50, was expressed as peak power (PP50), time to peak power (TtPP50), 
peak force (PF50) and time to peak force (TtPF50). Start of the measurements where 
considered to be when there was one successive increasing positive measurements of velocity 
higher than 0.010 m/s, followed by an increase in measured position until PP50 and PF50 was 
achieved. End of the measurements was considered to be at highest measured values in force 
and power in the concentric phase of the extension.  
During the MVIC test seated in the leg extension apparatus, the subjects kept the contraction 
for 3 seconds. Measurements of the MVIC were expressed as maximal force value. During 
the isometric test the plate loaded knee extension apparatus was locked (Fig. 5).  
Different customizations where made to ensure reproducibility and similarity of the 
movement for each athlete. We wanted to limit the compensatory movements, so the MVC 
and MVIC measurements could be related only to the force generated in the muscles normally 
involved in the leg extension exercise. Seated in the leg extension apparatus the athletes 
where stringed at the hip with a belt system, and had support in a backrest. The arm of the 
knee extension apparatus was placed at the superior extensor retinaculum (Fig. 4).  
Statistical analyses 
All data were checked for normality by use of the Shapiro-Wilks test and are presented as 
mean and standard deviation (SD). To examine within group effects of ST on the power and 
force variables investigated, the paired samples t-test procedure was performed when there 
were only two repeated measurements on the variable. A one-factor analysis of variance 
(ANOVA) was performed when there was three repeated measurements on the variable 
involved, e.g. when comparing PP50 in the baseline with PP50 with and without use of ST. A 
two-factor within subjects ANOVA was carried out when testing for differences between use 
and non-use of ST during the repeated measurements of PP50 and PF50 after fatiguing the knee 
extensors. These analyses, if significant, were followed-up by paired samples t-test and 
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adjusted for multiple comparisons by use of the Bonferroni correction. Statistical significance 
was set at p < 0.05.  
Sample size estimation was made on the basis of PP50 in a pilot study and calculated 
according to Kleinbaum et al. (1998: 29) to find the minimum sample size required to detect a 
difference of 1.5 SD. With a level of significance at p < 0.05 and a power on 0.8, < 7 persons 
were needed to reveal a difference of 176 N. 
Also, intraclass correlation coefficients (ICC) were calculated for the two dependent variables 
PP50 and PF50 in the pilot study. Four subjects with similar characteristics as the subjects in 
this study participated in the pilot study. Four repeated measurements of PP50 and PF50 by use 
of the MuscleLab showed an average ICC of 0.96 and 0.92, respectively. The values of ICC 
for single measures were 0.86 and 0.74 for PP50 and PF50.  
 
RESULTS 
Differences in Peak Power and Time to Peak Power 
The power measurements in the MVC50 for the whole group are presented below (Fig. 7).  
The subjects’ individual peak power scores during the MVC50 are presented in Fig.8.    
No significant differences were revealed in any of the scores obtained in baseline and 
recovery tests, with or without ST in PP50 (F 2/15=0.05; P=0.95) mean PP50 (t5=0.02; P=0.99) 
and TtPP50 (F 2/15=0.27; P=0.77). 
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Figure 7: A: The subjects highest measured PP50 at baseline, as well as with and without ST in the recovery test. 
B: The subjects mean PP50 during the recovery test with and without ST. C: The subjects TtPP50 during the 
highest measured PP50 value at baseline, as well as with and without ST. All variables are presented as means ± 
SD (N=6). 
 
 
 
Figure 8: Peak Power values at MVC50 for each subject at baseline, as well as with and without ST in the 
recovery test. 
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The PP50 in each of the repetitions during the two recovery tests, with and without ST, are 
given in Fig. 9 for all subjects pooled. There was a significant effect of time in the PP50 during 
the recovery test, (F7/35 = 3.20, P = 0.01), but no effect of ST (F1/5=0.16, P=0.70) or 
interaction between time and ST (F7/35=0.26, P=0.97) were revealed. Figure 9 is based on the 
first 15 min of the recovery tests, because there was missing values later on in these time-
series due to different end-points for each subject. Each subjects´ individual PP50 scores 
during the two recovery tests are shown in Fig. 10, with their own baseline PP50 score as the 
reference line. At average it took the subjects 12.5 ± 6.1 min and 10.0 ± 4.5 min to return 
back to the baseline PP50 score during the recovery tests with and without ST, respectively. 
The time it took to recover PP50 back to baseline level did not differ between these two 
conditions (t5 = 1.01, P=0.36). 
 
 
Figure 9: The mean power measurements in a MVC50 for all subjects from 1 min to 15 min during the recovery 
test (N=6). *= Significant different from the first measurement for all subjects and both conditions pooled; 
*P<0.05, **<0.01 ***<0.001. #=Significant different from the second measurement for all subjects and both 
conditions pooled; #P<0.05. §= Significant different from the third measurements for all subjects and both 
condition pooled; §P<0.05. Only observations during the first 15 min, which are common for all subjects, are 
given in the figure. The subjects had different end-points. 
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Figure 10: The figure shows each subjects power measurements in a MVC50 during repeated measurements 
every other minute in the recovery tests with or without ST. The figure shows the values from the 1
st
 minute 
until the recovery test was ended. The straight line indicates the subjects PP50 value in a MVC50 at baseline. 
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Differences in Peak Force and Time to Peak Force 
The force measurements in the MVC50 for the whole group are presented below (Fig. 11).  
The subjects’ individual peak force scores during the MVC50 are presented in Fig.12.    
No significant differences were revealed obtained from the baseline scores, with or without 
ST in PF50 during the recovery tests (F 2/15=0.16; P=0.85). The subjects mean PF50 proved to 
be significant higher with ST than without during the recovery test (t5=2.77; P=0.04), and the 
TtPF50 was significantly higher than the scores obtained in baseline, compared to the test 
without ST during the recovery test (F 2/15=3.94; P=0.04). 
 
Figure 11: A: The subjects highest measured PF50 at baseline, as well as with and without ST in the recovery 
test. B: The subjects mean PF50 during the recovery test with and without ST. C: The subjects TtPF50 during the 
highest measured PF50 value at baseline, as well as with and without ST. All variables are presented as means ± 
SD (N=6). 
 
17 
 
 
Figure 12: Peak force values at MVC50 for each subject at baseline, as well as with and without ST in the 
recovery test. 
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The PF50 in each of the repetitions during the two recovery tests, with and without ST, are 
given in Fig. 13 for all subjects pooled. There were no significant effect of time (F7/35=1.38, 
P=0.24), ST (F1/5=4.42, P=0.09), or the interaction between time and ST (F7/35=1.33, 
P=0.27) in the PF50 during the recovery test. Figure 13 is based only on the first 15 min of the 
recovery test, in order to include all subjects. However, on average it took the subjects ~19 
min to recover PF50 back to baseline level with use of ST during the recovery test and, 
therefore, we had to perform a separate paired samples t-test between with and without ST to 
test for different time in returning PF50 back to baseline level. This analyze revealed 
significant longer recovery period with use of ST (Mean: 18.5 min; SD: 7.3) compared to 
without use of ST (Mean: 8.7 min; SD:4.5; t5=3.25, P=0.02).
 
 
Figure 13: The mean force measurements for all subjects at MVC50 during the recovery test (N=6). Only 
observations during the first 15 min, which are common for all subjects, are given in the figure. The subjects 
had different end-points. Note: The subjects reached their baseline PF50 scores with ST later than after 15 min 
(see text for more details). 
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Figure 14: The figure shows each subjects force measurements in a MVC50 during repeated measurements 
every other minute in the recovery period with or without ST. The figure shows the values from the 1st min 
until the recovery test was ended. The straight line indicates the subjects PF50 value in a MVC50 at baseline. 
 
 
 
Differences in isometric maximal voluntary contraction Force 
The force measurements in the MVIC for the whole group are presented below (Fig. 15)  
The MVIC at baseline proved to be significantly higher than the MVIC scores during the 
recovery test without ST (F2/10=5.20;P=0.03).   
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Figure 15:  The Maximal Voluntary Isometric Contractions obtained at baseline, as well as with and without ST. 
The values are presented as means and ± SD (N=6). *=Significant higher score in baseline MVIC (P=0.03). 
 
DISCUSSION  
 
Main findings 
The main findings in this study showed a significant delayed time of recovery, with use of ST 
compared to without use of ST, during PF50 in each of the repetitions during the two recovery 
tests, and no significant differences in PP50, and TtPP50 with or without ST were proved. 
Differences in peak power and time to peak power 
No significant differences were proven in this study, upon any of the scores obtained in 
baseline and during the recovery tests, with or without ST in PP50, mean PP50 and TtPP50. 
Escher et al. (1998) reported the same observation, with no significant differences in reaction 
time and force during test with and without ST. The MVC50 measurements in this study 
showed that four of the subjects achieved a higher PP50 without ST according to the PP50 
measurements with ST in the recovery test (Fig.8), but the findings did not differ 
significantly.  
The PP50 in each of the repetitions during the two recovery tests, with and without ST, proved 
a significant effect of time in the PP50 during the recovery test, but no effect of ST, or 
interaction between time and ST were revealed. At average it took the subjects 2.5 min longer 
to return back to the baseline PP50 score during the recovery tests with ST, compared to 
without ST. Despite the difference, it was not found significant. 
Differences in peak force and time to peak force 
No significant differences were revealed obtained from the baseline scores, with or without 
ST in PF50 during the recovery tests, but the subjects mean PF50 proved to be significant 
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higher with ST than without during the recovery test, and the TtPF50 was significantly higher 
than the scores obtained in baseline, compared to the test without ST during the recovery test. 
The differences in TtPF50 might have several causes. The baseline tests were the first ones 
accomplished, and the significant improvement from baseline to the tests without ST, might 
be due to an improved technique in the leg-extension exercise. Four off six subjects’ achieved 
higher PF50 values with ST than without ST, but it did not differ significantly (Fig.12).      
The PF50 in each of the repetitions during the two recovery tests, with and without ST, proved 
no significant effect of time or the interaction between time and ST in the PF50 during the 
recovery test. But because that the above mentioned findings were based only on the first 15 
min of the recovery test (in order to include all subjects), a separate paired samples t-test 
between with and without ST to test for different time in returning PF50 back to baseline level 
was performed. The analyze revealed a 9.5 min significant longer recovery period with use of 
ST, compared to without. 
The measurements according to MVIC, proved a significant higher force at baseline, 
compared to MVIC force during the test without ST.  
Summary considerations 
It could be reasonable to believe that ST exerts a negative effect upon performance, and 
increase the time of recovery after muscle fatigue. However, many studies have failed to 
prove a decreased performance (Van Duser & Raven, 1992; Escher, 1998; Edquist, 2004; 
Karlsen, 2004), and as mentioned initially vigorous literature searches have not proven 
successful in finding any studies examining the effect of ST upon recovery time. Most of the 
studies have proved increased HR (Guggenheimer, 1991; Edquist, 2004), increased secretion 
of epinephrine and norepinephrine (Cryer et al., 1976; Guggenheimer, 1991; Lumbardo, 1998; 
Edquist, 2004),  and raised levels of lactate at given workloads or efforts (Van Duser & 
Raven, 1992). Several studies have indicated, that raised levels of lactate are observed with 
ST compared to the same tests without ST. It is also proved increase of H+ ions and Pi when 
raised levels of lactate, is observed. The metabolites H+ and Pi has been suggested as possible 
sites for pheripheral fatigue and a decreased performance, when they interfere the Ca2+ 
binding to troponin C  (Vøllestad 1997; Westerblad & Allen, 2002). Vøllestad (1997) points 
to that the interference of raised metabolites levels, results in fewer binding sites to the 
myosin at the actin, resulting in a decreased force per cross-bridge (Åstrand et al., 2003). 
Considering this, it is however surprising that no studies have achieved to prove significant 
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differences in performance with and without ST. A possible weakness of the studies is that all 
the tested subjects are regular ST users over several years, and it is tempting to speculate, 
whether the effect of ST exerts a greater impairment to non regular users of ST. In addition, 
you could imagine that the differences had been easier to prove in vitro, compared to the tests 
on MVC, endurance, isotonic or isometric contractions, which have several limitations. 
Many authors (Bigeland-Ritchie et al., 1983; Löscher et al., 1996; Taylor et al.,2000) claims 
that fatigue during substained muscle actions, might be due to both pheripheral and central 
fatigue. However, fatigue has mainly proved to be due to peripheral factors, when there is a 
sufficient rest between each action (Bigeland-Ritchie et al., 1986). Simultaneously Vøllestad 
(1997) refers to that MVC might be due to both central and peripheral fatigue. In light of 
these findings it is difficult to state the exact underlying mechanism for the fatigue shown in 
this study. Taken Westerblad & Allen (2002) findings in consideration, it is tempting to 
suggest that the fatigue mainly were due to peripheral factors. It might be factors such as 
insufficient supply of energy through the aerobic/anaerobic pathways, metabolic factors such 
as lactate, H+ and Pi, reduced Ca2+ release from SR and the decreased Ca2+ sensitivity at the 
troponi C, but as noted it will be only speculations.    
Limitations 
In the present study, as numerous other studies that includes MVC, there are limitations. 
Vøllestad (1997) points to that psychological factor such as motivation can vary within the 
group tested. The task they were given during the MVC was to perform maximal effort. For 
the author in this investigation, there is no guarantee that the subjects managed to perform a 
maximal effort with proper technique at each MVC, which is a possible site for differences in 
the measurements.  The subjects were told not to exercise vigorously the day before testing, 
but this is difficult to completely control. In addition, there might be different muscle fiber 
composition within the group tested. Bigeland-Ritchie et al. (1986) refers to that the 
impairment of the performance resulting from muscle fatigue, might differ according muscle 
fiber type. 
During the days of testing, the subjects had a tight match schedule, which also may have 
inhibited the test results. None of the tests were conducted the day after a match. However, it 
is a possibility that the subjects not were completely recovered when performing the actual 
test in this study. 
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The leg extension apparatus applied in this study was old, and the resistance of the levers, 
pulleys and cams involved may have differed.   
The sample size estimation was made on the basis of PP50 in a pilot study and calculated 
according to Kleinbaum et al. (1998: 29) to find the minimum sample size required to detect a 
difference of 1.5 SD. However, it could have been more appropriate to calculate sample size 
according to an ANOVA design. 
CONCLUSION 
During the present study, the main focus of interest was to investigate the effect of ST upon 
recovery time. Specifically we wanted to see if use of ST would lead to delayed time of 
recovery in muscular force and power, following a fatiguing leg extension exercise. We also 
wanted to see if the PF and PP would be lower, and TtPF and TtPP would be higher, with use 
of ST than without. 
Some of our findings indicated a conferment of the hypothesis, for example the significant 
observation with longer time of recovery back to the obtained baseline PF50 scores with ST. 
Another observation was that the PP50 in each repetitions during the recovery test for all the 
subjects, pictured a small difference in the PP50 values achieved, respectively with and 
without ST, and higher PP50 values were found without ST, than with ST. 
Another observation was that the PF50 measurements during the recovery period with and 
without ST, pictured bigger differences than between the PP50 measurements during the 
recovery period, with and without ST. The reason for this difference is unknown, but there 
might seem as the interaction between ST upon force and power in this investigation differs. 
A conclusion for this investigation is that muscle power and force does not seem to differ 
significantly with or without ST. The differences in time of recovery with and without ST was 
proved significant in the force tests, but not in the power tests. The PP50, PF50, TtPP50 and 
TtPF50 do not seem to be either significantly improved or impaired with use of ST.  
On behave of these findings, it is difficult to state the exact effect of ST upon recovery time, 
because there is no certain pattern in the findings, and further research is required. 
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